CytomX Therapeutics Appoints Rachael Lester as Chief Business Officer
Provided By GlobeNewswire
Last update: Oct 20, 2025
SOUTH SAN FRANCISCO, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced the appointment of Rachael Lester as Senior Vice President, Chief Business Officer. In this role, Ms. Lester will lead the Company’s strategy and business development functions.
Read more at globenewswire.com
